It is possible that the AMPK/mTOR/ULK1 signaling is differentially regulated at various NAFLD stages since a recent study reported that inhibition of mTOR signaling during early NAFLD was gradually restored in later stages16. The gene discussed is ULK1; the disease is metabolic dysfunction-associated steatotic liver disease.